Friday, 19 Oct 2018

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – Cocoon...

20 Jul 2018

Dr. Rachel Tate: RISE Registry

07 Nov 2017

Dr. Olga Petryna: Cardiovascular risk...

12 Jun 2017

The RheumNow Week in Review – No Good...

10 Aug 2018

Dr. Rachel Tate: Adalimumab and Disease...

07 Nov 2017

RheumNow Week in Review – RheumNow Live...

21 Sep 2018

Dr. Carol Langford: MOC resources

09 Nov 2015

Dr. Alvin Wells: Telemedicine

08 Nov 2017

The RheumNow Week in Review – 17...

17 Feb 2017

Dr. Janet Pope: Pre-op for Total Hip or...

07 Nov 2017

RWCS 2017: A Curious Case of Anasarca

21 Feb 2017

RheumNow Week in Review – 16 December...

16 Dec 2016